A multi-agent digital twin–enabled decision support system for sustainable and resilient supplier management

Li, Y.L.; Tsang, Y.P.; Wu, C.H.; Lee, C.K.M.

doi:10.1016/j.cie.2023.109838

Cited by 8 publications

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The extended duration of drug development, which can span up to 15 years, is exacerbated by the substantial time scientists spend sourcing knowledge, hindered by inadequate information sharing [6,7]. Thus, knowledge sharing (KS) emerges as a strategic Sustainability 2024, 16, 2460 2 of 19 imperative to enhance innovation capabilities within this knowledge-intensive sector [2,8]. While trade secrets are integral to preserving competitive advantage and stimulating innovation [9], the securitization of these secrets should not impede the knowledge sharing within firms that is crucial for advancing innovation.…”

Section: Introductionmentioning

confidence: 99%

Enhancing Competitiveness through Strategic Knowledge Sharing as a Driver of Innovation Capability and Performance

Yuen,

Lam

2024

Sustainability

View full text Add to dashboard Cite

In an era marked by global challenges, for example, the COVID-19 pandemic, the pharmaceutical sector stands at the forefront of innovation, tasked with delivering therapeutic breakthroughs at an unprecedented pace. This study ventures beyond the well-trodden path by probing the intricate dynamics of knowledge sharing as a strategic catalyst for bolstering innovation capability and performance (ICP) within pharmaceutical firms. We argue that knowledge sharing transcends conventional utility, acting as a pivotal lever that amplifies innovation within a highly regulated and competitive landscape. Through meticulous analysis, we unearth a nuanced synergy among six pivotal domains—organizational culture, managerial commitment, technological infrastructure, trust, reciprocal benefits, and knowledge dissemination. Our research model, anchored in a robust body of literature, reveals that while these elements individually support ICP, their collective orchestration through knowledge-sharing networks yields a magnified impact on innovation outcomes. We present novel insights illustrating that the interplay between these domains and knowledge-sharing practices engenders a fertile ecosystem for innovation, where diverse stakeholders contribute to richer, more robust ICP. Our findings underscore the strategic imperative for pharmaceutical firms to cultivate an integrated knowledge-sharing culture, not merely as good practice but as a cornerstone for sustained innovation and competitive superiority in a rapidly evolving industry.

show abstract